Senior Scientific Director
Johnson & Johnson Innovative Medicine
Damayanthi Devineni, PhD is a Senior Scientific Director at Johnson & Johnson Innovative Medicine and has over 24 years of experience in the pharmaceutical industry. Prior to joining Johnson & Johnson Innovative Medicine, she worked at Novartis Pharmaceuticals and Aventis Pharmaceuticals and has expertise in cross-functional interactions under multinational cultures. Dr. Devineni s responsible for developing and driving clinical pharmacology and pharmacometric strategies for projects within the Neurodegeneration Disease area stronghold (DAS) and the Retinal DAS. She is also a people leader managing colleagues who support clinical programs across these DAS. She also represents Janssen on an external cross-pharma IQ consortium that drives the discipline’s scientific excellence forward for organ impairment studies.